Related Experiment Video
Updated: May 31, 2026
06:08
Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Gene-PUFA interactions and obesity risk
C Jourdan1, S Kloiber, A Nieters
1Institute of Epidemiology, Helmholtz Zentrum München, German Research Centre for Environmental Health, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany.
The British Journal of Nutrition
|July 9, 2011
Summary
Polyunsaturated fatty acids (PUFA) may modify obesity risk associated with specific gene variants. Higher PUFA intake, particularly linoleic and arachidonic acid, correlated with reduced obesity risk in carriers of certain gene variants, notably IL-6.
Area of Science:
- Nutritional genomics
- Obesity research
- Human genetics
Background:
- Limited human data exists on polyunsaturated fatty acids (PUFA) modulating the link between single nucleotide polymorphisms (SNPs) and obesity risk.
- Investigating gene-PUFA interactions is crucial for understanding obesity etiology.
Purpose of the Study:
- To examine the interaction effects between SNPs in obesity-related genes and erythrocyte membrane PUFA levels on obesity risk in adults.
- To identify specific gene variants and PUFA that influence obesity susceptibility.
Main Methods:
- Cross-sectional analysis of 568 adults from the Bavarian Food Consumption Survey.
- Gas chromatography (GC) for erythrocyte membrane fatty acid composition.
- Genotyping for 21 candidate genes and measurement of plasma IL-6 concentrations.
- Logistic regression modeling for additive genetic effects.
Main Results:
- Significant interactions between PUFA and gene variants (IL-2, IL-6, IL-18, TNFRSF1B, TNFRSF21, LEPR, ADPN) were observed for obesity risk.
- Strongest effects noted for rs2069779 (IL-2) with all PUFA and rs1800795 (IL-6) with linoleic/arachidonic acid.
- Obesity risk decreased with higher fatty acid content in minor allele carriers, particularly for IL-6 variants.
- The PUFA-IL-6 genetic interaction was reflected in plasma IL-6 levels.
Conclusions:
- Polyunsaturated fatty acids may exert regulatory effects on obesity risk through interactions with specific gene variants.
- High PUFA intake, especially linoleic and arachidonic acid, may offer a protective effect against obesity for individuals with certain genetic profiles.
- Further prospective studies are needed to confirm these findings and their public health implications.
Related Concept Videos
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.